Trump Plans to Fire FDA Commissioner Marty Makary
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- President Trump has reportedly signed off on a plan to dismiss FDA Commissioner Marty Makary, according to WSJ, Bloomberg, and Politico.
- Marty Makary faced political pushback after trying to block flavored vape approvals, prompting President Trump to demand their approval to win over young voters.
- Marty Makary also delayed a safety study on the abortion pill mifepristone, angering anti‑abortion groups and some Republican lawmakers.
- The White House's plan to oust Makary would leave the FDA without a permanent commissioner, adding to existing vacancies in the Health and Human Services Department that require Senate confirmation.
- Marty Makary missed his scheduled address at the FDA's annual 5K race, according to two agency sources.
Why it matters: Makary loses his post, the FDA faces another leadership gap, and the Trump administration can install a more politically aligned commissioner, but Senate confirmation will delay the appointment.
Ask SkimNews
